التفاصيل البيبلوغرافية
العنوان: |
LBA45 First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study) |
المؤلفون: |
Ascierto, P.A., Mandala, M., Ferrucci, P.F., Rutkowski, P., Guidoboni, M., Fernandez, A.M. Arance, Ferraresi, V., Maiello, E., Guida, M., Del Vecchio, M., Fierro, M.T., Queirolo, P., Lebbé, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Chiarion Sileni, V. |
المصدر: |
In Annals of Oncology September 2020 31 Supplement 4:S1173-S1174 |
قاعدة البيانات: |
ScienceDirect |